The Pharmacokinetics of 4% Lidocaine Gel When Applied Topically to the Breasts
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Plasma concentration of lidocaine and MEGX after one-time application of 4% lidocaine gel (TOPICAINE) on the skin of the breasts and chest wall as recommended for use as as pre-medication to reduce discomfort during screening mammography.
Prior to gel application, and at 30 min, 60, min, and 2, 3, 4, 6, and 8 hours after
Colleen K Lambertz, MSN, FNP
St. Luke's Mountain States Tumor Institute
United States: Institutional Review Board
|St. Luke's Mountain States Tumor Institute||Boise, Idaho 83712|